BIODYSSEY
Live / Applied — Non-final action mailed (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 29 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99468511
- Mark type
- Stylized text
- Filed
- 29 Oct 2025
- Attorney of record
- Daniel P. Mullarkey
Goods and services
- Class 005 — Pharmaceuticals: Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments
- Class 042 — Scientific and technological services: Scientific research; Scientific research and development in the fields of oncology, radiopharmaceuticals, and cancer treatment; Pharmaceutical research and development of new radiopharmaceutical agents; Design and testing of radiopharmaceutical drugs for cancer diagnosis and therapy; Laboratory research, testing, and analysis in the field of nuclear medicine and targeted radiotherapy; Providing scientific information in the field of biochemistry, biotechnology, pharmaceutical research and development, and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
Owner
- Biodyssey Therapeutics, Inc., Van Nuys, CA, US
Prosecution history
- 20 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION WRITTEN
- 13 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Oct 2025 — NEW APPLICATION ENTERED